Culturally Tailored Integrated Harm Reduction Program for Black and Latinx Adults Who Use Drugs

What this Trial Is About

Researchers are evaluating an integrated harm reduction intervention IHRI compared to usual harm reduction services for Black and Latinx people who use drugs PWUD. The study aims to improve the use of harm reduction services among this highly marginalized population. The trial is interventional and focuses on addressing substance abuse and related mental health issues through culturally tailored support. The integrated harm reduction intervention lasts 8 weeks and includes weekly education lessons during the first 4 weeks led by an IHRI care coordinator. During the following 4 weeks, participants receive personalized identification of social vulnerabilities to connect them with relevant social service organizations. Both the IHRI group and the usual harm reduction services group interact with mobile vans providing information on syringe exchange, clean user kits, naloxone use, and fentanyl strip distribution. Participants will be involved for up to 8 weeks, with researchers monitoring their attendance at harm reduction sessions and changes in substance use patterns, overdose risk, and quality of life. Key measurements include the percentage attending harm reduction sessions, changes in days of opioid or stimulant use, overdose risk assessment scores, and quality of life scores. The study includes random assignment to groups and does not involve masking or blinding.

Harm Reduction Services